Distribution of different ingredients at the same IDDSI level (Percentage and frequency) and statistical significance analysis (Chi-square test)^b'*'. حسب Muxi Chen (9294270)

الموضوعات:

MIP receptor expression in <i>N. lugens</i>: relative quantification of <i>mipr</i> transcript levels in different developmental stages (A) and tissues (B) of <i>N. lugens.</i> حسب Yi-Jie Zhang (713506)

Relative quantification of <i>mip</i> transcript levels in different developmental stages (A) and tissues (B) of brown planthopper. حسب Yi-Jie Zhang (713506)

Some examples of selected Chinese characters. حسب Weijia Zhu (65481)

"…Our model shows clear enhancements in structural accuracy (SSIM improved to 0.91), pixel-level fidelity (RMSE reduced to 2.68), perceptual quality aligned with human vision (LPIPS reduced to 0.07), and stylistic realism (FID decreased to 13.87). …"

Changes in the distribution of average sleep duration. حسب Hea Ree Park (10769827)

الموضوعات:

Changes in symptoms of insomnia and excessive daytime sleepiness during the COVID-19 pandemic by age. حسب Hea Ree Park (10769827)

الموضوعات:

Changes in sleep patterns before versus during the COVID-19 pandemic by age. حسب Hea Ree Park (10769827)

الموضوعات:

Sociodemographic characteristics. حسب Hea Ree Park (10769827)

الموضوعات:

Changes in sleep habits and sleep-related symptoms. حسب Hea Ree Park (10769827)

الموضوعات:

Regression analysis of sleep habits and sleep-related symptoms associated with pandemic status. حسب Hea Ree Park (10769827)

الموضوعات:

Study flow chart. حسب Hea Ree Park (10769827)

الموضوعات:

Novel Small-Molecule miR-124 Inducer Acts as “a Physiological Brake” of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis حسب Tiantian Wang (1688881)

"…We found that FHND5032 significantly upregulated miR-124 expression in macrophages, surpassing the clinical-stage comparator ABX464 in vitro and in vivo. …"

Green Hydrogen Economy: Scenarios versus Technologies حسب Hua Fan (495346)

"…Our findings reveal that operational scenarios can reduce LCOH more significantly than technological improvements alone. …"

Receptivity of virgin and mated females after seminal fluid protein candidate genes were knocked down by dsRNA injections, scored as the percentage of females that copulated within... حسب Yi-Jie Zhang (713506)

Changes in the neutrophil count. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

Changes in the platelet count. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

Changes in the white blood cell count. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

Changes in the hemoglobin. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

WBC and ANC on day 7 post-chemotherapy. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"

General clinical data of 88 patients with NPC. حسب Lu Yang (30847)

"…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"